Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Johnson & Johnson ( (JNJ) ) has issued an announcement.
On March 31, 2025, Johnson & Johnson announced that the U.S. Bankruptcy Court for the Southern District of Texas denied the request by its subsidiary, Red River Talc LLC, to confirm its proposed prepackaged bankruptcy plan. As a result, the company will reverse approximately $7 billion from amounts previously reserved for the bankruptcy resolution, impacting its financial planning and potentially affecting stakeholders’ expectations.
More about Johnson & Johnson
Johnson & Johnson is a multinational corporation operating in the pharmaceutical, medical devices, and consumer health sectors. The company is known for its wide range of products, including pharmaceuticals, medical devices, and consumer health products, with a strong market presence globally.
YTD Price Performance: 8.29%
Average Trading Volume: 9,522,254
Technical Sentiment Signal: Strong Sell
Current Market Cap: $369.3B
For a thorough assessment of JNJ stock, go to TipRanks’ Stock Analysis page.